In conclusion, we believe that HLA-G can serve as a potential prognostic factor as well as therapeutic target in tumors, especially in renal cell carcinoma and thyroid carcinoma. The gene discussed is HLA-G; the disease is hereditary clear cell renal cell carcinoma.